LEADER 01750nam  2200469zu 450 
001 9910698399303321
005 20250721195136.0
035   $a(CKB)3860000000008819
035   $a(SSID)ssj0001125815
035   $a(PQKBManifestationID)12502169
035   $a(PQKBTitleCode)TC0001125815
035   $a(PQKBWorkID)11133810
035   $a(PQKB)10112372
035   $a(MiFhGG)0PIP
035   $a(OCoLC)44224825
035   $a(EXLCZ)993860000000008819
100   $a20160829d2004      uy 
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt
182   $cc
183   $acr
200 00$aClub Drugs
205   $a[Rev.].
210 31$a[Place of publication not identified]$cGreenhaven Press Incorporated Imprint$d2004
215   $a1 electronic text $cHTML file
225 1 $aCommunity drug alert bulletin
300   $aBibliographic Level Mode of Issuance: Monograph
330 8 $aFeatures a community drug alert bulletin concerning methylenedioxymethamphetamine (MDMA), or ecstasy, Gamma-hydroxybutyrate (GHB), Rohypnol, ketamine, methamphetamine, and lysergic acid diethylamide (LSD), collectively known as "club drugs" for their prominence at night clubs and parties. Describes the street name, effects and reasons for use, and medical consequences of each drug, provided by the National Institute of Drug Abuse (NIDA) within the U.S. National Institutes of Health (NIH).
606   $aNightclubs
606   $aDrugs
615  0$aNightclubs.
615  0$aDrugs.
676   $a615.7883
676   $a362.29
702   $aBalkin$b Karen$f1949-
712 02$aNational Institute on Drug Abuse.
801  0$bPQKB
906   $aBOOK
912   $a9910698399303321
996   $aClub drugs$92987403
997   $aUNINA